Steris | STE - Current Assets


Steris reported $2.39B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
3M USD 14.39B 1.99B Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
Avanos Medical USD 325M 30.4M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
CONMED USD 670.59M 2.27M Mar/2026
Cooper Companies USD 2.3B 166M Mar/2026
Dexcom USD 4.33B 298.4M Mar/2026
Ecolab USD 6.04B 87.1M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Fortive USD 1.55B 58.5M Mar/2026
Getinge SEK 18.16B 1.83B Dec/2024
Globus Medical USD 2.2B 72.51M Mar/2026
Haemonetics USD 834.88M 108.8M Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Intuitive Surgical USD 11.52B 881.5M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Olympus JPY 706.31B 53.66B Mar/2026
Orthofix International USD 461.52M 44.67M Mar/2026
Owens Minor USD 588.5M 40.63M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
Steris USD 2.39B 108.4M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026